Last 12 months
Inside the activity.
0 purchase rows · 30 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 9 |
| May 2026 | 0 | 7 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 6 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 3 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 16, 2026 Filed Apr 20, 2026 12:54 UTC |
LICHTMAN MOSHEDirector
|
SaleOrdinary Shares | 3,750 | $1.47 | $5,512.50 |
DisclosureSEC source: 0001976408-26-000347 · primary_doc.xml · nonDerivative · entry 1 LICHTMAN MOSHE · CIK 0001685868 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held by NGR Ltd. An entity wholly owned by the reporting person Disclosed balance after: 126,450 F1 · kind: The shares sold represent shares withheld and sold by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted share units F2 · ownership.nature: This Form 4 reports only the transaction effected by NGR Ltd. No transactions occurred with respect to other securities beneficially owned by the reporting person. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 12:22 UTC |
Chairman DavidSVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,384 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001976408-26-000346 · primary_doc.xml · derivative · entry 3 Chairman David · CIK 0001971553 · SVP, R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 91,695 Underlying: Ordinary Shares · 2,384 shares Expires 2031-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 12:22 UTC |
Chairman DavidSVP, R&D
|
SaleOrdinary Shares | 2,384 | $1.50 | $3,587.68 |
DisclosureSEC source: 0001976408-26-000346 · primary_doc.xml · nonDerivative · entry 2 Chairman David · CIK 0001971553 · SVP, R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 403,968 F1 · kind: The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 F3 · shares: The shares sold were acquired upon the exercise of stock options on the same date F4 · price: The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request. Read SEC document |
| April 16, 2026 Filed Apr 20, 2026 12:22 UTC |
Chairman DavidSVP, R&D
|
Exercise / conversionOrdinary Shares | 2,384 | $0.86 | $2,050.24 |
DisclosureSEC source: 0001976408-26-000346 · primary_doc.xml · nonDerivative · entry 1 Chairman David · CIK 0001971553 · SVP, R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 406,352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 F2 · shares: The shares were acquired upon the exercise of stock options Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 12:19 UTC |
Chairman DavidSVP, R&D
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,616 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001976408-26-000344 · primary_doc.xml · derivative · entry 4 Chairman David · CIK 0001971553 · SVP, R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 94,079 Underlying: Ordinary Shares · 5,616 shares Expires 2031-06-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · kind: The options reported herein were exercised and the underlying shares were sold on the same date as reported in Table I. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 12:19 UTC |
Chairman DavidSVP, R&D
|
SaleOrdinary Shares | 1,616 | $1.49 | $2,408.81 |
DisclosureSEC source: 0001976408-26-000344 · primary_doc.xml · nonDerivative · entry 3 Chairman David · CIK 0001971553 · SVP, R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 403,968 F1 · kind: The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 F3 · shares: The shares sold were acquired upon the exercise of stock options on the same date F4 · price: The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 12:19 UTC |
Chairman DavidSVP, R&D
|
SaleOrdinary Shares | 4,000 | $1.46 | $5,853.60 |
DisclosureSEC source: 0001976408-26-000344 · primary_doc.xml · nonDerivative · entry 2 Chairman David · CIK 0001971553 · SVP, R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 405,584 F1 · kind: The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 F3 · shares: The shares sold were acquired upon the exercise of stock options on the same date F4 · price: The price reported is a weighted average price. The reporting person undertakes to provide full information, regarding the number of shares and prices at which the transaction was effectuated, upon request. Read SEC document |
| April 15, 2026 Filed Apr 16, 2026 12:19 UTC |
Chairman DavidSVP, R&D
|
Exercise / conversionOrdinary Shares | 5,616 | $0.86 | $4,829.76 |
DisclosureSEC source: 0001976408-26-000344 · primary_doc.xml · nonDerivative · entry 1 Chairman David · CIK 0001971553 · SVP, R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 409,584 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported on this Form 4 were effectuated pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 16, 2024 F2 · shares: The shares were acquired upon the exercise of stock options Read SEC document |
| March 30, 2026 Filed Mar 30, 2026 13:58 UTC |
Rozenberg Haine YaelVP Finance
|
GrantOrdinary Shares | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001976408-26-000301 · primary_doc.xml · nonDerivative · entry 1 Rozenberg Haine Yael · CIK 0001991398 · VP Finance 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 162,649 F1 · kind: The Reporting Person was granted restricted stock units ("RSUs"), which each represent a contingent right to receive one share of ordinary stock of Valens Semiconductor Ltd. (the "Company"). The units vest 25% on the first Vesting Date (03/30/2027) and the remaining 75% vest in twelve equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Company or its subsidiaries through each vesting date. Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 10:27 UTC |
Yaacobi TalDirector
|
SaleOrdinary Shares | 1,400 | $1.11 | $1,554.00 |
DisclosureSEC source: 0001976408-26-000307 · primary_doc.xml · nonDerivative · entry 1 Yaacobi Tal · CIK 0002122521 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,398 F1 · kind: The shares sold represent shares withheld and sold by the Issuer to satisfy tax withholding obligations in connection with the vesting of restricted share units Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.